MSD announces £3.1m Scottish Life Sciences Fund to Support Next Generation of Life Scientists
MSD (operating in the US and Canada as Merck & Co,. Inc) and SULSA are delighted to announce the launch of the MSD Scottish Life Sciences Fund to support Drug Discovery Research and the recruitment and training of the next generation of Life Scientists in Scotland.
MSD will provide over £3 million to the Fund over a three year period together with £300k from the Scottish Funding Council (SFC) who will administer the Fund and £350K from SULSA who will distribute the Fund.
It will be used to support Life Sciences training at the undergraduate, doctoral and postdoctoral levels in six Scottish Universities: Aberdeen, Dundee, Edinburgh, Glasgow, St Andrews and Strathclyde, to provide high-quality research and training opportunities for outstanding candidates.
Chris Hill, MSD Global Head of Chemistry, on announcing the Fund said: "Scotland is increasingly gaining recognition for the excellence of its life sciences sector."
"We believe the MSD Scottish Life Sciences Fund will have a long lasting effect on the Scottish Life Sciences academic community and provide long term benefits for the Scottish economy by training a new generation of drug discovery scientists and promoting the exchange of knowledge to the wider Scottish Scientific community."
"MSD is proud to have supported this through strategic alliances with Scottish universities over many years and is proud to be continuing to make a contribution through the launch of this Fund."
Scottish Health Secretary Nicola Sturgeon said: "We are delighted that MSD has the trust and belief in Scotland and our world renowned University research base. This trust has been forged over many years of working closely with our researchers, businesses and academics and it is something we can all be proud of."
“This Fund offers a fantastic opportunity for our research base to contribute to and enhance the economic development of the Life Sciences in Scotland as well as helping to grow the reputation and talent of the sector and Scotland as a whole.”
Mark Batho, Chief Executive of the Scottish Funding Council said: “This is a significant investment for life sciences research in Scotland from a global healthcare company. It reflects the world-leading quality of Scottish university research which has been strengthened in recent years by the creation of SFC-funded research pools such as SULSA. The new fund, directed at early-career researchers, will help to maintain this excellence well into the future."
SULSA director, Professor Andrew Hopkins said: "We are delighted that MSD, the SFC and Scottish Universities have chosen SULSA to develop and deliver this ambitious research and training programme across Scotland.
"This choice is testament to the added value that SULSA can bring to large-scale collaborative projects through its governance structure, commitment to research excellence and powerful research networks. The MSD Scottish Life Sciences Fund will have a lasting impact on the local drug discovery community, a community that is widely recognised to deliver world-class research."
Tue, 03/12/2013 - 11:44
Maciej Antkowiak, a researcher associated with the SULSA Bioworkstation at the University of St...
SULSA and ETP catalyse new research collaborations between Hong Kong and Scotland in the Life Sciences and Energy
Wed, 06/11/2013 - 17:40
Through a series of workshops facilitated by SULSA and ETP, and an agreement signed by SFC and UGC,...
Fri, 18/10/2013 - 10:19
The RSE is pleased to open the call for applications for the Scottish Enterprise and BBSRC funded...
Thu, 19/09/2013 - 13:58
A recent debate, held by the Scottish Universities Life Sciences Alliance (SULSA), and chaired by...